Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA.

J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601.

PMID:
20874515
2.

Response to a monovalent 2009 influenza A (H1N1) vaccine.

Greenberg ME, Lai MH, Hartel GF, Wichems CH, Gittleson C, Bennet J, Dawson G, Hu W, Leggio C, Washington D, Basser RL.

N Engl J Med. 2009 Dec 17;361(25):2405-13. doi: 10.1056/NEJMoa0907413. Epub 2009 Sep 10.

3.

Cognitive response to memantine in moderate to severe Alzheimer disease patients already receiving donepezil: an exploratory reanalysis.

Schmitt FA, van Dyck CH, Wichems CH, Olin JT; Memantine MEM-MD-02 Study Group.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):255-62.

PMID:
17132970
4.

A systematic review of assessment and treatment of moderate to severe Alzheimer's disease.

Schmitt FA, Wichems CH.

Prim Care Companion J Clin Psychiatry. 2006;8(3):158-9.

5.

Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter.

Kim DK, Tolliver TJ, Huang SJ, Martin BJ, Andrews AM, Wichems C, Holmes A, Lesch KP, Murphy DL.

Neuropharmacology. 2005 Nov;49(6):798-810. Epub 2005 Sep 23.

PMID:
16183083
6.

Brain region-specific alterations of 5-HT2A and 5-HT2C receptors in serotonin transporter knockout mice.

Li Q, Wichems CH, Ma L, Van de Kar LD, Garcia F, Murphy DL.

J Neurochem. 2003 Mar;84(6):1256-65.

7.

Genetic perspectives on the serotonin transporter.

Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch KP, Uhl G.

Brain Res Bull. 2001 Nov 15;56(5):487-94. Review.

PMID:
11750794
8.

Molecular mechanisms of cocaine reward: combined dopamine and serotonin transporter knockouts eliminate cocaine place preference.

Sora I, Hall FS, Andrews AM, Itokawa M, Li XF, Wei HB, Wichems C, Lesch KP, Murphy DL, Uhl GR.

Proc Natl Acad Sci U S A. 2001 Apr 24;98(9):5300-5.

10.

Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.

Li Q, Wichems C, Heils A, Van De Kar LD, Lesch KP, Murphy DL.

J Pharmacol Exp Ther. 1999 Dec;291(3):999-1007.

PMID:
10565817
11.

Molecular manipulations as tools for enhancing our understanding of 5-HT neurotransmission.

Murphy DL, Wichems C, Li Q, Heils A.

Trends Pharmacol Sci. 1999 Jun;20(6):246-52. Review.

PMID:
10366867
13.

Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice.

Sora I, Wichems C, Takahashi N, Li XF, Zeng Z, Revay R, Lesch KP, Murphy DL, Uhl GR.

Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7699-704.

14.

Altered brain serotonin homeostasis and locomotor insensitivity to 3, 4-methylenedioxymethamphetamine ("Ecstasy") in serotonin transporter-deficient mice.

Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mössner R, Westphal H, Lesch KP.

Mol Pharmacol. 1998 Apr;53(4):649-55.

PMID:
9547354
15.

Functional characterization of the murine serotonin transporter gene promoter in serotonergic raphe neurons.

Heils A, Wichems C, Mössner R, Petri S, Glatz K, Bengel D, Murphy DL, Lesch KP.

J Neurochem. 1998 Mar;70(3):932-9.

17.

Novel 2-substituted cocaine analogs: uptake and ligand binding studies at dopamine, serotonin and norepinephrine transport sites in the rat brain.

Bennett BA, Wichems CH, Hollingsworth CK, Davies HM, Thornley C, Sexton T, Childers SR.

J Pharmacol Exp Ther. 1995 Mar;272(3):1176-86.

PMID:
7891330

Supplemental Content

Loading ...
Support Center